Efficacy and Safety of Narrow Focus (F1) Versus Wide Focus (F3) of Shock Wave Lithotripsy (SWL) for Renal Calculi

Overview

This study aims to compare the narrow focus (F1) versus the wide focus (F3) in terms of the efficacy of Shock Wave Lithotripsy (SWL) in the management of renal calculi 1-2 cm and their injurious effect on the kidney.

Full Title of Study: “Which is Better: Narrow vs. Wide Focus for Shock Wave Lithotripsy of Renal Stones”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: September 30, 2023

Detailed Description

Recently, some Shock Wave Lithotripsy (SWL) devices have been announced in the market with a different focus points. One early experimental study found that stone disintegration is better with small focusing points than larger focusing points. Nevertheless, these findings, in terms of the efficacy of stone disintegration, need to be validated in-vivo. Furthermore, the effect of focal size on renal injury during SWL need to be studied as well. Therefore, the objectives of this study are to compare the effect of using the narrow focus of 2mm (F1) versus the wide focus of 8 mm (F3) on the Stone Free Rate (SFR) following SWL for renal stones 1-2cm and estimating renal injury effect of F1 vs. F3 by urinary renal injury markers such as neutrophil gelatinase-associated lipocalin (NGAL) for assessment of proximal and distal renal tubules injury & Kidney Injury Molecule-1 (KIM-1) for assessment of proximal renal tubules injury). The SWL device: Lithotripter type: Piezo Lith3000 plus ( from Richard Wolf, Germany.

Interventions

  • Procedure: Shock Wave Lithotripsy (SWL)
    • Shock Wave Lithotripsy (SWL) with focal size 2mm (F1), and 3000 shocks or Shock Wave Lithotripsy (SWL) with focal size 8mm (F3), and 3000 shocks

Arms, Groups and Cohorts

  • Active Comparator: Group 1
    • Group 1 will undergo Shock Wave Lithotripsy (SWL) with focal size 2mm (F1), and 3000 shocks
  • Active Comparator: Group 2
    • Group 2 will undergo Shock Wave Lithotripsy (SWL) with focal size 8mm (F3), and 3000 shocks

Clinical Trial Outcome Measures

Primary Measures

  • Assessment of efficacy of Shock Wave Lithotripsy (SWL) by calculation of the percentage (%) of stone free
    • Time Frame: 1 year
    • Assessment of efficacy of Shock Wave Lithotripsy (SWL) and its success by calculation of stone free (%) following each session with a maximum of 3 Shock Wave Lithotripsy (SWL) sessions, 2 weeks a part, using pelvi-abdominal Ultrasound (US) and Kidney-Ureter-Bladder (KUB) and the presence of significant residual stone >4 mm will be considered “non-stone free” and the final stone free status (%) will be calculated at one month following the last session of Shock Wave Lithotripsy (SWL). Shock Wave Lithotripsy (SWL) failure will be defined as failure to reach stone free status (%) one month after 3rd session.

Secondary Measures

  • Assessment of the degree of renal injury using renal injury markers
    • Time Frame: 1 year
    • Assessment of the degree of renal injury using renal injury markers as follow: – Urine analysis for neutrophil gelatinase-associated lipocalin (NGAL) (ng/dL) & Kidney Injury Molecule 1 (KIM-1) (ng/dL) will be measured measured with enzyme-linked immunosorbent assay (ELISA) method before, 2 hours after and 72 hours after the 1st Shock Wave Lithotripsy (SWL) session.
  • Assessment of the presence of peri-renal hematoma
    • Time Frame: 1 year
    • Assessment of the presence of peri-renal hematoma will be conducted as follow: – Ultrasonography (US) will be done 24 hours after Shock Wave Lithotripsy (SWL) session to search for the presence of peri-renal hematoma and measure its size (cc).
  • Assessment of the changes in renal cortical thickness
    • Time Frame: 1 year
    • Changes in the renal cortical thickness will be assessed as follow: – Ultrasonography (US) will be done before and after 6 months post Shock Wave Lithotripsy (SWL) for assessment of renal cortical thickness (mm) and the pre- and post-SWL measurements will be compared
  • Measurement of the changes in the Renal Resistive Index (RRI)
    • Time Frame: 1 year
    • Renal Resistive Index (RRI) will be measured in the arcuate arteries using the following formula “RRI can be calculated as (peak systolic velocity – end diastolic velocity)/peak systolic velocity” before and 24 hours after Shock Wave Lithotripsy (SWL) using Doppler Ultrasound and changes will be recorded

Participating in This Clinical Trial

Inclusion Criteria

1. Adult patients (>18years old) with 1-2 cm single renal stone. 2. Normal functioning kidney. Exclusion Criteria:

1. Pregnancy. 2. Bleeding diatheses. 3. Radiolucent stones. 4. Radio-opaque stones with Hounsfield Unit (HU) > 1200 5. Patients with a pacemaker. 6. Active Urinary Tract Infection (UTI). 7. Severe skeletal malformations. 8. Morbid obesity with Body Mass Index (BMI) ≥40 kg/m2. 9. Renal artery aneurysm at the same site of the stone. 10. Anatomical obstruction distal to the stone. 11. Patients with renal impairment with serum creatinine > 1.2 mg/dL.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Benha University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Yasser A. Noureldin, Assistant Professor of Urology – Benha University
  • Overall Official(s)
    • Yasser Noureldin, MD, PhD, Principal Investigator, Benha University
    • Ahmed Abdelbaky, MD, PhD, Study Chair, Benha University
    • Walid Ibrahim, MD, PhD, Study Director, Benha University
    • Ezzat Elnahife, MD, Study Director, Benha University
    • Salah El Hamshary, MD, PhD, Study Director, Benha University
  • Overall Contact(s)
    • Yasser Noureldin, MD, PhD, 01225352115, dryasser.noor@fmed.bu.edu.eg

References

Turney BW, Reynard JM, Noble JG, Keoghane SR. Trends in urological stone disease. BJU Int. 2012 Apr;109(7):1082-7. doi: 10.1111/j.1464-410X.2011.10495.x. Epub 2011 Aug 26.

Connors BA, Evan AP, Blomgren PM, Handa RK, Willis LR, Gao S. Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ramping. BJU Int. 2009 Jan;103(1):104-7. doi: 10.1111/j.1464-410X.2008.07922.x. Epub 2008 Aug 1.

Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011 Apr;23(2):194-200. doi: 10.1097/MOP.0b013e328343f4dd.

Veser J, Jahrreiss V, Seitz C, Ozsoy M. The effect of focus size and intensity on stone fragmentation in SWL on a piezoelectric lithotripter. World J Urol. 2020 Oct;38(10):2645-2650. doi: 10.1007/s00345-019-03069-y. Epub 2020 Jan 10.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.